469 related articles for article (PubMed ID: 38522008)
1. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.
Jayawickrama SM; Ranaweera PM; Pradeep RGGR; Jayasinghe YA; Senevirathna K; Hilmi AJ; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2045. PubMed ID: 38522008
[TBL] [Abstract][Full Text] [Related]
2. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
Solis RN; Silverman DA; Birkeland AC
Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
[TBL] [Abstract][Full Text] [Related]
3. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning.
Wang Y; Zhou C; Li T; Luo J
J Cell Mol Med; 2024 May; 28(9):e18394. PubMed ID: 38751024
[TBL] [Abstract][Full Text] [Related]
5. Translational research in head and neck cancer: Molecular and immunological updates.
Kumai T; Shinomiya H; Shibata H; Takahashi H; Kishikawa T; Okada R; Fujieda S; Sakashita M
Auris Nasus Larynx; 2024 Apr; 51(2):391-400. PubMed ID: 37640594
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
Ebnoether E; Muller L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
[TBL] [Abstract][Full Text] [Related]
8. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
Li Q; Chen W; Li Q; Mao J; Chen X
Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
[TBL] [Abstract][Full Text] [Related]
9. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
11. Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma.
Devaraja K
Pharmaceut Med; 2019 Aug; 33(4):269-289. PubMed ID: 31933185
[TBL] [Abstract][Full Text] [Related]
12. Personalized cancer vaccination in head and neck cancer.
Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
[TBL] [Abstract][Full Text] [Related]
13. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
14. Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine.
Wu J; Yuan Y; Tao XF
Chin Med J (Engl); 2020 Jun; 133(11):1325-1336. PubMed ID: 32404691
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the immune cell function landscape in head and neck squamous carcinoma to assist in prognosis prediction and immunotherapy.
Wang W; Zhang Z; Li W; Wei D; Xu J; Qian Y; Cao S; Lei D
Aging (Albany NY); 2023 Nov; 15(21):12588-12617. PubMed ID: 37955651
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
Franzen A; Bootz F; Dietrich D
HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy.
Gu Z; Yao Y; Yang G; Zhu G; Tian Z; Wang R; Wu Q; Wang Y; Wu Y; Chen L; Wang C; Gao J; Kang X; Zhang J; Wang L; Duan S; Zhao Z; Zhang Z; Sun S
Sci Transl Med; 2022 Sep; 14(661):eabo5987. PubMed ID: 36070368
[TBL] [Abstract][Full Text] [Related]
19. Genomics and precision surgery for head and neck squamous cell carcinoma.
Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
[TBL] [Abstract][Full Text] [Related]
20. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P; Bourhis J; Psyrri A
Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]